Aztreonam: Review of the clinical experience and potential uses in pediatrics

M. H. Lebel, G. H. McCracken

Research output: Contribution to journalArticle

17 Scopus citations

Abstract

Aztreonam (Azactam®) is a novel antimicrobial agent that belongs to a new family of monocyclic beta-lactam antibiotics, the monobactams. Its antimicrobial spectrum of activity and relative lack of toxicity are among the many unique properties that make it attractive for use in infants and children. The purposes of this review are to provide an overview of the spectrum of activity, pharmacokinetic properties, clinical experience and potential uses in the pediatric patient.

Original languageEnglish (US)
Pages (from-to)331-339
Number of pages9
JournalPediatric Infectious Disease Journal
Volume7
Issue number5
Publication statusPublished - 1988

    Fingerprint

ASJC Scopus subject areas

  • Microbiology (medical)
  • Pediatrics, Perinatology, and Child Health

Cite this

Aztreonam : Review of the clinical experience and potential uses in pediatrics. / Lebel, M. H.; McCracken, G. H.

In: Pediatric Infectious Disease Journal, Vol. 7, No. 5, 1988, p. 331-339.

Research output: Contribution to journalArticle